Journal of Endocrinology · 1969 · 137 citations · 0 references
Life SciencesBiochemistryEndocrinologyHormone BiochemistryReproductive EndocrinologySteroid BiochemistryAndrogen PhysiologyGonadal HormonesGonadal Steroid HormonesHormone Binding ProteinsHormone ReceptorsNuclear ReceptorsAndrogen Action In ProstateAndrogen ReceptorsBiochemical CharacterizationEquilibrium DialysisHormone Receptor Binding ProteinsNuclear Hormone ReceptorsRadioactivity MeasurementSex Hormone Receptors
SUMMARY The specificity of the binding of [1,2- 3 H]testosterone to nuclei of various rat tissues in vivo has been studied. A significant amount of radioactivity was retained in the nuclei of androgen-dependent tissues only, particularly the ventral prostate gland. The bound radioactivity was only partially recovered as [1,2- 3 H]testosterone; the remainder was identified as [ 3 H]5α-dihydrotestosterone. Efforts were made to characterize the binding component, or 'receptor', in prostatic nuclei. On digestion of nuclei labelled in vivo with [1,2- 3 H]testosterone, with enzymes of narrow substrate specificity, only trypsin released tritium, suggesting that the receptor is a protein. On the basis of subfractionation studies of labelled nuclei, the receptor is an acidic protein. The androgen—receptor complex could be effectively extracted from the prostatic nuclei in 1 m -NaCl and from the results of fractionations on a calibrated agarose column, the complex has a molecular weight 100,000–120,000. The specificity of the binding of steroids to such 1 m -NaCl extracts in vitro was investigated by the equilibrium dialysis procedure. Under these conditions, the specificity of the binding of [1,2- 3 H]testosterone demonstrated in vivo could not be simulated. The receptor is probably part of the chromatin complex but its precise intranuclear localization cannot be determined by biochemical procedures alone.